BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34104323)

  • 1. Loperamide Toxicity Revealing Apical Hypertrophic Cardiomyopathy.
    Khan N; Chitturi KR; Hatcher C; Clewing M; Nagueh SF
    Methodist Debakey Cardiovasc J; 2021 Apr; 17(1):65-67. PubMed ID: 34104323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias, and Cardiomyopathy Associated With Loperamide Abuse.
    Vaughn P; Solik MM; Bagga S; Padanilam BJ
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1230-1233. PubMed ID: 27461785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Loperamide-Induced Ventricular Storm.
    De Vera J; Kim HB; Sakr AE
    J Investig Med High Impact Case Rep; 2021; 9():2324709621990768. PubMed ID: 33533290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.
    Kang J; Compton DR; Vaz RJ; Rampe D
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apical hypertrophic cardiomyopathy with hemodynamically unstable ventricular arrhythmia - Atypical presentation.
    Chaturvedi H; Pandey RD; Sharma KK; Makkar JS; Sharma SK
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S202-S206. PubMed ID: 27751289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loperamide abuse cardiotoxicity. Should loperamide still be an over the counter medication?
    Idris A; Mihora DC; Kaye K
    Am J Emerg Med; 2018 Sep; 36(9):1716.e1-1716.e3. PubMed ID: 29779679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes in loperamide toxicity: Case report and review of literature.
    Teigeler T; Stahura H; Alimohammad R; Kalahasty G; Koneru JN; Ellenbogen M; Ellenbogen KA; Padala SK
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2618-2626. PubMed ID: 31432581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loperamide Abuse and Its Sequelae.
    Strzyzewski L; Key P; Jones P; Prahlow JA
    Am J Forensic Med Pathol; 2020 Sep; 41(3):207-210. PubMed ID: 32796207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia.
    Holloway CJ; Betts TR; Neubauer S; Myerson SG
    J Am Coll Cardiol; 2010 Nov; 56(23):1961. PubMed ID: 21109122
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragmented QRS is associated with ventricular tachycardia in patients with apical aneurysm with hypertrophic cardiomyopathy.
    Baysal E; Yaylak B; Altıntaş B
    Indian Heart J; 2016; 68(2):199. PubMed ID: 27133337
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case Report of Torsade de Pointes and Brugada Pattern Associated with Loperamide Misuse and Supratherapeutic Loperamide Concentrations.
    Simon M; Rague J
    J Emerg Med; 2021 Oct; 61(4):e54-e59. PubMed ID: 34127340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model.
    Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Reinke F; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2021 Mar; 21(3):248-254. PubMed ID: 33125619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report].
    Kono K; Higashi T; Hara K; Mori S; Ito I; Shinbo G; Anzai R; Yagi H; Tamano K; Horinaka S; Matsuoka H
    J Cardiol; 2001 Dec; 38(6):343-9. PubMed ID: 11806092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia associated with high-dose chronic loperamide use.
    Spinner HL; Lonardo NW; Mulamalla R; Stehlik J
    Pharmacotherapy; 2015 Feb; 35(2):234-8. PubMed ID: 25645123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide complex tachycardia and cardiomyopathy: What would you do?
    Ahmed A; Freeland S; Steinberg L; Prystowsky EN
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1171-1173. PubMed ID: 29847001
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained ventricular tachycardia as a first manifestation of hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm in an elderly female patient.
    Dilaveris P; Aggeli C; Synetos A; Skiadas I; Antoniou CK; Tsiamis E; Gatzoulis K; Kallikazaros I; Tousoulis D
    Ann Noninvasive Electrocardiol; 2017 May; 22(3):. PubMed ID: 28012232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Torsade de pointes following repeated massive loperamide ingestions].
    Myllymäki L; Westerbergh J; Carlsson H; Höjer J
    Lakartidningen; 2020 Jan; 117():. PubMed ID: 32016923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loperamide abuse - constipation or heart attack?].
    Gunnarsdottir AK; Johannsson M; Haraldsson M; Bjarnadottir GD
    Laeknabladid; 2018 Dec; 104(12):543-548. PubMed ID: 30511645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm.
    Lim KK; Maron BJ; Knight BP
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):445-7. PubMed ID: 19054248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.